Logo image of VEEV

VEEVA SYSTEMS INC-CLASS A (VEEV) Stock Fundamental Analysis

NYSE:VEEV - New York Stock Exchange, Inc. - US9224751084 - Common Stock - Currency: USD

234.98  -3.08 (-1.29%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to VEEV. VEEV was compared to 37 industry peers in the Health Care Technology industry. VEEV scores excellent points on both the profitability and health parts. This is a solid base for a good stock. VEEV is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes VEEV very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

VEEV had positive earnings in the past year.
VEEV had a positive operating cash flow in the past year.
In the past 5 years VEEV has always been profitable.
In the past 5 years VEEV always reported a positive cash flow from operatings.
VEEV Yearly Net Income VS EBIT VS OCF VS FCFVEEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

With an excellent Return On Assets value of 9.73%, VEEV belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
With an excellent Return On Equity value of 12.24%, VEEV belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
VEEV has a Return On Invested Capital of 9.79%. This is amongst the best in the industry. VEEV outperforms 91.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VEEV is above the industry average of 6.37%.
The 3 year average ROIC (9.16%) for VEEV is below the current ROIC(9.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.73%
ROE 12.24%
ROIC 9.79%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
VEEV Yearly ROA, ROE, ROICVEEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

The Profit Margin of VEEV (26.00%) is better than 94.59% of its industry peers.
In the last couple of years the Profit Margin of VEEV has remained more or less at the same level.
With an excellent Operating Margin value of 25.36%, VEEV belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
In the last couple of years the Operating Margin of VEEV has remained more or less at the same level.
VEEV's Gross Margin of 74.53% is amongst the best of the industry. VEEV outperforms 81.08% of its industry peers.
VEEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.36%
PM (TTM) 26%
GM 74.53%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
VEEV Yearly Profit, Operating, Gross MarginsVEEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VEEV is destroying value.
Compared to 1 year ago, VEEV has more shares outstanding
The number of shares outstanding for VEEV has been increased compared to 5 years ago.
There is no outstanding debt for VEEV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VEEV Yearly Shares OutstandingVEEV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
VEEV Yearly Total Debt VS Total AssetsVEEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

VEEV has an Altman-Z score of 17.59. This indicates that VEEV is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 17.59, VEEV belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
VEEV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.59
ROIC/WACC0.9
WACC10.88%
VEEV Yearly LT Debt VS Equity VS FCFVEEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

VEEV has a Current Ratio of 4.51. This indicates that VEEV is financially healthy and has no problem in meeting its short term obligations.
VEEV has a Current ratio of 4.51. This is amongst the best in the industry. VEEV outperforms 86.49% of its industry peers.
VEEV has a Quick Ratio of 4.51. This indicates that VEEV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.51, VEEV belongs to the top of the industry, outperforming 86.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 4.51
VEEV Yearly Current Assets VS Current LiabilitesVEEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

7

3. Growth

3.1 Past

VEEV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.57%, which is quite impressive.
VEEV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.72% yearly.
VEEV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.20%.
VEEV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.99% yearly.
EPS 1Y (TTM)36.57%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%26.09%
Revenue 1Y (TTM)16.2%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%14.31%

3.2 Future

Based on estimates for the next years, VEEV will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.05% on average per year.
Based on estimates for the next years, VEEV will show a quite strong growth in Revenue. The Revenue will grow by 13.21% on average per year.
EPS Next Y12.6%
EPS Next 2Y11.46%
EPS Next 3Y11.93%
EPS Next 5Y14.05%
Revenue Next Year11.87%
Revenue Next 2Y11.81%
Revenue Next 3Y12.35%
Revenue Next 5Y13.21%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VEEV Yearly Revenue VS EstimatesVEEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
VEEV Yearly EPS VS EstimatesVEEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.55, which means the current valuation is very expensive for VEEV.
Based on the Price/Earnings ratio, VEEV is valued cheaper than 81.08% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.35, VEEV is valued a bit more expensive.
The Price/Forward Earnings ratio is 31.57, which means the current valuation is very expensive for VEEV.
Based on the Price/Forward Earnings ratio, VEEV is valued a bit cheaper than 75.68% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VEEV to the average of the S&P500 Index (22.20), we can say VEEV is valued slightly more expensively.
Industry RankSector Rank
PE 35.55
Fwd PE 31.57
VEEV Price Earnings VS Forward Price EarningsVEEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VEEV is valued a bit cheaper than 67.57% of the companies in the same industry.
72.97% of the companies in the same industry are more expensive than VEEV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.8
EV/EBITDA 40.24
VEEV Per share dataVEEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VEEV does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of VEEV may justify a higher PE ratio.
PEG (NY)2.82
PEG (5Y)1.44
EPS Next 2Y11.46%
EPS Next 3Y11.93%

0

5. Dividend

5.1 Amount

No dividends for VEEV!.
Industry RankSector Rank
Dividend Yield N/A

VEEVA SYSTEMS INC-CLASS A

NYSE:VEEV (5/28/2025, 3:59:51 PM)

234.98

-3.08 (-1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)05-28 2025-05-28/amc
Inst Owners84.77%
Inst Owner Change0.53%
Ins Owners8.83%
Ins Owner Change0.05%
Market Cap38.29B
Analysts77.37
Price Target267.62 (13.89%)
Short Float %2.45%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.29%
Min EPS beat(2)7.97%
Max EPS beat(2)8.61%
EPS beat(4)4
Avg EPS beat(4)5.82%
Min EPS beat(4)3.17%
Max EPS beat(4)8.61%
EPS beat(8)8
Avg EPS beat(8)5.77%
EPS beat(12)11
Avg EPS beat(12)5.29%
EPS beat(16)15
Avg EPS beat(16)5.79%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-0.82%
Max Revenue beat(4)1.09%
Revenue beat(8)2
Avg Revenue beat(8)-0.57%
Revenue beat(12)2
Avg Revenue beat(12)-0.57%
Revenue beat(16)4
Avg Revenue beat(16)-0.26%
PT rev (1m)-1.68%
PT rev (3m)-0.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.79%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)5.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 35.55
Fwd PE 31.57
P/S 13.94
P/FCF 35.8
P/OCF 35.13
P/B 6.57
P/tB 7.16
EV/EBITDA 40.24
EPS(TTM)6.61
EY2.81%
EPS(NY)7.44
Fwd EY3.17%
FCF(TTM)6.56
FCFY2.79%
OCF(TTM)6.69
OCFY2.85%
SpS16.86
BVpS35.79
TBVpS32.82
PEG (NY)2.82
PEG (5Y)1.44
Profitability
Industry RankSector Rank
ROA 9.73%
ROE 12.24%
ROCE 11.72%
ROIC 9.79%
ROICexc 73.54%
ROICexgc 189.64%
OM 25.36%
PM (TTM) 26%
GM 74.53%
FCFM 38.94%
ROA(3y)9.59%
ROA(5y)10.49%
ROE(3y)12.23%
ROE(5y)13.63%
ROIC(3y)9.16%
ROIC(5y)11.04%
ROICexc(3y)59.89%
ROICexc(5y)59.49%
ROICexgc(3y)196.73%
ROICexgc(5y)318.62%
ROCE(3y)10.96%
ROCE(5y)13.22%
ROICexcg growth 3Y-36.21%
ROICexcg growth 5Y-13.57%
ROICexc growth 3Y1.45%
ROICexc growth 5Y14.29%
OM growth 3Y-2.45%
OM growth 5Y-0.44%
PM growth 3Y4.03%
PM growth 5Y-0.95%
GM growth 3Y0.79%
GM growth 5Y0.55%
F-Score7
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 52.1%
Cap/Sales 0.75%
Interest Coverage 250
Cash Conversion 148.14%
Profit Quality 149.76%
Current Ratio 4.51
Quick Ratio 4.51
Altman-Z 17.59
F-Score7
WACC10.88%
ROIC/WACC0.9
Cap/Depr(3y)59.59%
Cap/Depr(5y)52.02%
Cap/Sales(3y)0.83%
Cap/Sales(5y)0.77%
Profit Quality(3y)158.47%
Profit Quality(5y)158.74%
High Growth Momentum
Growth
EPS 1Y (TTM)36.57%
EPS 3Y21.12%
EPS 5Y24.72%
EPS Q2Q%26.09%
EPS Next Y12.6%
EPS Next 2Y11.46%
EPS Next 3Y11.93%
EPS Next 5Y14.05%
Revenue 1Y (TTM)16.2%
Revenue growth 3Y14.06%
Revenue growth 5Y19.99%
Sales Q2Q%14.31%
Revenue Next Year11.87%
Revenue Next 2Y11.81%
Revenue Next 3Y12.35%
Revenue Next 5Y13.21%
EBIT growth 1Y62.24%
EBIT growth 3Y11.27%
EBIT growth 5Y19.47%
EBIT Next Year18.21%
EBIT Next 3Y15.23%
EBIT Next 5Y17.62%
FCF growth 1Y20.83%
FCF growth 3Y12.54%
FCF growth 5Y19.82%
OCF growth 1Y19.61%
OCF growth 3Y12.55%
OCF growth 5Y20.04%